Latest filing published 27 Aug 2026 for Arcutis Biotherapeutics, Inc., €820k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Terrie Curran: trading record in brief
Terrie Curran discloses dealings in Arcutis Biotherapeutics, Inc. to SEC (Form 4). Between 20 August 2026 and 27 August 2026, the trades on record add up to 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 27 August 2026, the filings show a transaction worth €820k in Arcutis Biotherapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Terrie Curran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,200 shares@ US$25.0294CommonSEC144:0001628280-26-059254
- 1,072 shares@ US$26.03760.0008% mcap100.0% of flowCommonSEC144:0001628280-26-058275
2 of 2 declarations
